Major Run on UNVC (Univec Conglomerate Inc) As Co
Post# of 4861
(Total Views: 27605)
Posted On: 02/14/2021 12:02:33 PM
Major Run on UNVC (Univec Conglomerate Inc) As Co Beefs up BOD & Eyes Major Exchange 0
BY BOE RIMES ON FEBRUARY 13, 2021
Post Views: 353
UNVC (Univec Conglomerate Inc) is in full beat mode rocketing up the charts in recent months from the low double zeroes last summer to recent highs of $0.165 per share. The stock has been under heavy accumulation recently and volume has picked up substantially with NSAV regularly trading millions of shares and topping $1 million in dollar volume per day. UNVC started its move up in December moving up off the triple zeroes and moving northbound as a new era of penny stock speculators fueled by robinhood and its 100 million new trading accounts take on the bulletin boards. These are different times than just a few short years ago; now penny stocks such as TSNP can achieve a $6 billion plus market valuation and trade $375 million in dollar volume in a day on the bulletin boards. And TSNP has no stronger fundamentals than UNVC does.
There is a lot to get excited about on UNVC which has been rising dramatically thanks to a low float and a tightly held stock structure that’s not selling. The Company is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System. UNVC is developing the gold standard certified Transdermal CBD Patch and Opioid withdrawal solution that will be distributed WORLDWIDE after years of clinical trials and now a grow facility belonging to the Company’s conglomerate in Israel. The Company has partnerships with Harvest (HRVSF), RITE AID, Sativeo, Agrimed, Walmart, our PPSI and Wellness
Teladoc subsidiaries and Big Pharma most likely Merck as they were in Israel watching our clinical trials closely. UNVC is currently working with Euromed to corner Europe’s medical MJ market and Medicaid telemedicine and Medicare in America. The Company also recently stated it plans to up list to a major exchange. Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005 reporting at the time: “UNIVEC, Inc. (OTCMKTS: UNVC) has been running up the charts in recent months from a start point in triple zero land to recent highs of $0.0076. The stock has quickly attracted a large shareholder base which has been bidding this one higher.” Shareholders have stated concerns for UNVC lack of filings ore recent press releases.
UNVC (Univec Conglomerate Inc) formerly Univec, Inc. (Univec) is a public company which manufactures and distributes specialty pharmaceuticals and cannabis CBD. Physician and Pharmaceutical Services Inc, (PPSI is the pharmacy sample services division of UNVC) The Company operates as an integrated licensing, manufacturing, and marketing company operating two divisions dedicated to providing safer health products to patients and caregivers worldwide. The Company’s syringe division develops, licenses and markets auto-disable and safety syringes worldwide. The physician and pharmaceutical services division assists pharmaceutical companies in marketing, fulfillment and tracking drug samples via an online system connecting pharmacies and managed payment providers. The Company also manufactures and markets sliding sheath syringes designed to protect patients and healthcare workers from needle stick injuries, in compliance with the federal needlestick safety and prevention act of the United States government.
The Company is led by Dr David Dalton; a visionary who was named as one of the “Top 100 Healthcare Leaders” for 2019 by the International Forum on Advancements in Healthcare. With 45 years’ experience in the pharmaceutical world, Dr. Dalton served over 18 years as Vice President of Rite Aid, and then founded and served as Chairman, President, CEO of several successful pharmaceutical and pharmaceutical related companies including Mednet, ManagedcareRx, and Sivault Systems. Dr. Dalton is an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom. Dr. Dalton received a Doctor of Pharmacy from West Virginia University School of Pharmacy. In addition to his extensive background in pharmaceutical field, he is a visiting professor and lectures at several schools of pharmacy throughout the United States, and former President of West Virginia University School of Pharmacy Presidential Committee. Dr Dalton has built an impressive BOD for UNVC including John C. Peoples, Past Vice President of Merck as well as Kenneth Grant past Vice President of Johns Hopkins Health System.
Investor Sentiment on UNVC is high:
To Find out the inside Scoop on UNVC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
UNVC
UNVC has an impressive BOD; recently Kenneth Grant was elected to the UNVC BOD. Mr. Grant is a past Vice President of Johns Hopkins Health System. Dr. David Dalton, President/CEO of Univec Conglomerate Inc. states” We are delighted to welcome Kenneth Grant past Vice President of Johns Hopkins Health System to our Board of Directors. He brings extensive knowledge and many years of demonstrated professional skills in supply chain management in healthcare to the company.” Kenneth Grant was also responsible for Community Health Initiatives for the Johns Hopkins Health System. He did oversee over 600 employees responsible for carrying out these important functions. He also had oversight for the procurement of goods and services totaling in excess of $1.0 billion dollars. Over the course of his career Ken has been recognized and has received many awards both local and national.
JOHN C. PEOPLES past vice president of Merck also recently joined the Board of Directors of Univec Conglomerate Inc. bringing demonstrated professional skills in marketing management.
Dr. Dalton has stated he plans to roll a number of subsidiaries into Univec Conglomerate including Wellness Teladoc which has a big connection to TDOC. Wellness RX Medicaid in 26 states and Gold Standard for pharmacists. Time Organization CARF accredited Clinics to fight the opioid crisis. HRI Health Resources Inc PBM (Pharmacy benefits management) $204 Million revs last year (Docs private company for many years rolling up with the other private companies as he has alluded to. PPSI (always been a UNVC sub) Provides starter scripts to Doctors. Euromed Our Israeli medical cannabis company that has a grow license in Israel thru their subsidiary Eurocann Agritech. 30+ CBD meds for sale in Israel, the EU and US.
Image result for Univec Conglomerate Inc)The Company is developing the gold standard certified Transdermal CBD Patch and Opioid withdrawal solution that will be distributed WORLDWIDE after years of clinical trials and now a grow facility belonging to the Company’s conglomerate in Israel. The Company has partnerships with Harvest (HRVSF), RITE AID, Sativeo, Agrimed, Walmart, our PPSI and Wellness Teladoc subsidiaries and Big Pharma most likely Merck as they were in Israel watching our clinical trials closely. UNVC is currently working with Euromed to corner Europe’s medical MJ market and Medicaid telemedicine and Medicare in America.
Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005 reporting at the time: “UNIVEC, Inc. (OTCMKTS: UNVC) has been running up the charts in recent months from a start point in triple zero land to recent highs of $0.0076. The stock has quickly attracted a large shareholder base which has been bidding this one higher. Currently trading at a $7.5 million market valuation according to OTCMarketsgroup it looks as if there is a lot going on behind the scenes at Univec.”
For More on UNVC Subscribe Right Now!
UNVC is in full beat mode rocketing up the charts in recent months from the low double zeroes last summer to recent highs of $0.165 per share. The stock has been under heavy accumulation recently and volume has picked up substantially with NSAV regularly trading millions of shares and topping $1 million in dollar volume per day. UNVC started its move up in December moving up off the triple zeroes and moving northbound as a new era of penny stock speculators fueled by robinhood and its 100 million new trading accounts take on the bulletin boards. These are different times than just a few short years ago; now penny stocks such as TSNP can achieve a $6 billion plus market valuation and trade $375 million in dollar volume in a day on the bulletin boards. And TSNP has no stronger fundamentals than UNVC does. There is a lot to get excited about on UNVC which has been rising dramatically thanks to a low float and a tightly held stock structure that’s not selling. The Company is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System. UNVC is developing the gold standard certified Transdermal CBD Patch and Opioid withdrawal solution that will be distributed WORLDWIDE after years of clinical trials and now a grow facility belonging to the Company’s conglomerate in Israel. The Company has partnerships with Harvest (HRVSF), RITE AID, Sativeo, Agrimed, Walmart, our PPSI and Wellness Teladoc subsidiaries and Big Pharma most likely Merck as they were in Israel watching our clinical trials closely. UNVC is currently working with Euromed to corner Europe’s medical MJ market and Medicaid telemedicine and Medicare in America. The Company also recently stated it plans to up list to a major exchange. Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005. We will be updating on UNVC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with UNVC.
https://microcapdaily.com/major-run-on-unvc-u...nc/130397/
TOODLES
BY BOE RIMES ON FEBRUARY 13, 2021
Post Views: 353
UNVC (Univec Conglomerate Inc) is in full beat mode rocketing up the charts in recent months from the low double zeroes last summer to recent highs of $0.165 per share. The stock has been under heavy accumulation recently and volume has picked up substantially with NSAV regularly trading millions of shares and topping $1 million in dollar volume per day. UNVC started its move up in December moving up off the triple zeroes and moving northbound as a new era of penny stock speculators fueled by robinhood and its 100 million new trading accounts take on the bulletin boards. These are different times than just a few short years ago; now penny stocks such as TSNP can achieve a $6 billion plus market valuation and trade $375 million in dollar volume in a day on the bulletin boards. And TSNP has no stronger fundamentals than UNVC does.
There is a lot to get excited about on UNVC which has been rising dramatically thanks to a low float and a tightly held stock structure that’s not selling. The Company is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System. UNVC is developing the gold standard certified Transdermal CBD Patch and Opioid withdrawal solution that will be distributed WORLDWIDE after years of clinical trials and now a grow facility belonging to the Company’s conglomerate in Israel. The Company has partnerships with Harvest (HRVSF), RITE AID, Sativeo, Agrimed, Walmart, our PPSI and Wellness
Teladoc subsidiaries and Big Pharma most likely Merck as they were in Israel watching our clinical trials closely. UNVC is currently working with Euromed to corner Europe’s medical MJ market and Medicaid telemedicine and Medicare in America. The Company also recently stated it plans to up list to a major exchange. Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005 reporting at the time: “UNIVEC, Inc. (OTCMKTS: UNVC) has been running up the charts in recent months from a start point in triple zero land to recent highs of $0.0076. The stock has quickly attracted a large shareholder base which has been bidding this one higher.” Shareholders have stated concerns for UNVC lack of filings ore recent press releases.
UNVC (Univec Conglomerate Inc) formerly Univec, Inc. (Univec) is a public company which manufactures and distributes specialty pharmaceuticals and cannabis CBD. Physician and Pharmaceutical Services Inc, (PPSI is the pharmacy sample services division of UNVC) The Company operates as an integrated licensing, manufacturing, and marketing company operating two divisions dedicated to providing safer health products to patients and caregivers worldwide. The Company’s syringe division develops, licenses and markets auto-disable and safety syringes worldwide. The physician and pharmaceutical services division assists pharmaceutical companies in marketing, fulfillment and tracking drug samples via an online system connecting pharmacies and managed payment providers. The Company also manufactures and markets sliding sheath syringes designed to protect patients and healthcare workers from needle stick injuries, in compliance with the federal needlestick safety and prevention act of the United States government.
The Company is led by Dr David Dalton; a visionary who was named as one of the “Top 100 Healthcare Leaders” for 2019 by the International Forum on Advancements in Healthcare. With 45 years’ experience in the pharmaceutical world, Dr. Dalton served over 18 years as Vice President of Rite Aid, and then founded and served as Chairman, President, CEO of several successful pharmaceutical and pharmaceutical related companies including Mednet, ManagedcareRx, and Sivault Systems. Dr. Dalton is an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom. Dr. Dalton received a Doctor of Pharmacy from West Virginia University School of Pharmacy. In addition to his extensive background in pharmaceutical field, he is a visiting professor and lectures at several schools of pharmacy throughout the United States, and former President of West Virginia University School of Pharmacy Presidential Committee. Dr Dalton has built an impressive BOD for UNVC including John C. Peoples, Past Vice President of Merck as well as Kenneth Grant past Vice President of Johns Hopkins Health System.
Investor Sentiment on UNVC is high:
To Find out the inside Scoop on UNVC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
UNVC
UNVC has an impressive BOD; recently Kenneth Grant was elected to the UNVC BOD. Mr. Grant is a past Vice President of Johns Hopkins Health System. Dr. David Dalton, President/CEO of Univec Conglomerate Inc. states” We are delighted to welcome Kenneth Grant past Vice President of Johns Hopkins Health System to our Board of Directors. He brings extensive knowledge and many years of demonstrated professional skills in supply chain management in healthcare to the company.” Kenneth Grant was also responsible for Community Health Initiatives for the Johns Hopkins Health System. He did oversee over 600 employees responsible for carrying out these important functions. He also had oversight for the procurement of goods and services totaling in excess of $1.0 billion dollars. Over the course of his career Ken has been recognized and has received many awards both local and national.
JOHN C. PEOPLES past vice president of Merck also recently joined the Board of Directors of Univec Conglomerate Inc. bringing demonstrated professional skills in marketing management.
Dr. Dalton has stated he plans to roll a number of subsidiaries into Univec Conglomerate including Wellness Teladoc which has a big connection to TDOC. Wellness RX Medicaid in 26 states and Gold Standard for pharmacists. Time Organization CARF accredited Clinics to fight the opioid crisis. HRI Health Resources Inc PBM (Pharmacy benefits management) $204 Million revs last year (Docs private company for many years rolling up with the other private companies as he has alluded to. PPSI (always been a UNVC sub) Provides starter scripts to Doctors. Euromed Our Israeli medical cannabis company that has a grow license in Israel thru their subsidiary Eurocann Agritech. 30+ CBD meds for sale in Israel, the EU and US.
Image result for Univec Conglomerate Inc)The Company is developing the gold standard certified Transdermal CBD Patch and Opioid withdrawal solution that will be distributed WORLDWIDE after years of clinical trials and now a grow facility belonging to the Company’s conglomerate in Israel. The Company has partnerships with Harvest (HRVSF), RITE AID, Sativeo, Agrimed, Walmart, our PPSI and Wellness Teladoc subsidiaries and Big Pharma most likely Merck as they were in Israel watching our clinical trials closely. UNVC is currently working with Euromed to corner Europe’s medical MJ market and Medicaid telemedicine and Medicare in America.
Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005 reporting at the time: “UNIVEC, Inc. (OTCMKTS: UNVC) has been running up the charts in recent months from a start point in triple zero land to recent highs of $0.0076. The stock has quickly attracted a large shareholder base which has been bidding this one higher. Currently trading at a $7.5 million market valuation according to OTCMarketsgroup it looks as if there is a lot going on behind the scenes at Univec.”
For More on UNVC Subscribe Right Now!
UNVC is in full beat mode rocketing up the charts in recent months from the low double zeroes last summer to recent highs of $0.165 per share. The stock has been under heavy accumulation recently and volume has picked up substantially with NSAV regularly trading millions of shares and topping $1 million in dollar volume per day. UNVC started its move up in December moving up off the triple zeroes and moving northbound as a new era of penny stock speculators fueled by robinhood and its 100 million new trading accounts take on the bulletin boards. These are different times than just a few short years ago; now penny stocks such as TSNP can achieve a $6 billion plus market valuation and trade $375 million in dollar volume in a day on the bulletin boards. And TSNP has no stronger fundamentals than UNVC does. There is a lot to get excited about on UNVC which has been rising dramatically thanks to a low float and a tightly held stock structure that’s not selling. The Company is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System. UNVC is developing the gold standard certified Transdermal CBD Patch and Opioid withdrawal solution that will be distributed WORLDWIDE after years of clinical trials and now a grow facility belonging to the Company’s conglomerate in Israel. The Company has partnerships with Harvest (HRVSF), RITE AID, Sativeo, Agrimed, Walmart, our PPSI and Wellness Teladoc subsidiaries and Big Pharma most likely Merck as they were in Israel watching our clinical trials closely. UNVC is currently working with Euromed to corner Europe’s medical MJ market and Medicaid telemedicine and Medicare in America. The Company also recently stated it plans to up list to a major exchange. Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005. We will be updating on UNVC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with UNVC.
https://microcapdaily.com/major-run-on-unvc-u...nc/130397/
TOODLES
(4)
(0)Scroll down for more posts ▼